Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01582971 · ClinicalTrials.gov registry record · NA

Home-Based Symptom Management Via Reflexology for Breast Cancer Patients

A NA study, sponsored by Michigan State University.

Completed
Registry status
NA
Development phase
256
Enrollment target

NCT01582971: Completed NA study, sponsored by Michigan State University.

NCT01582971 is a NA study that has completed, run by Michigan State University. The registered enrollment target is 256 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01582971, a NA study, has completed, sponsored by Michigan State University.

COMPLETED
Registry status
NA
Development phase
256 participants
Enrollment target

Study Summary

The purpose of this project is to test foot reflexology delivered by a friend or family member in the home for women with breast cancer. The primary aims of the proposed study in a sample of women with breast cancer receiving chemotherapy and/or hormonal therapy are to determine the effects of 4 family- or friend-delivered weekly reflexology sessions compared to an attention control group.

Primary Outcome

The M.D. Anderson Symptom Inventory (MDASI) evaluates severity of 13 symptoms experienced by cancer patients (pain, fatigue, nausea, disturbed sleep, distress, shortness of breath, difficulty remembering, decreased appetite, drowsiness, dry mouth, sadness, vomiting, numbness/tingling) on the scale from 0=symptom not present to 10=as bad as you can imagine. Summed symptom severity score ranging from 0 to 130 was derived. MDASI also assesses how much symptoms interfered with 6 aspects of daily lif

Interventions

  • OTHER Reflexology

Trial Details

FieldValue
Enrollment Target 256 participants
Start Date 2012-04-17
Est. Completion 2016-05
Phase NA
Michigan State University

120 total trials

What the finished NCT01582971 record still lists

NCT01582971 is an interventional study that assigns participants to a tested intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 1 intervention - of which Reflexology is the first listed.

NCT01582971 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01582971 about?

NCT01582971 is a clinical study titled "Home-Based Symptom Management Via Reflexology for Breast Cancer Patients". The purpose of this project is to test foot reflexology delivered by a friend or family member in the home for women with breast cancer. The primary aims of the proposed study in a sample of women with breast cancer receiving chemotherapy and/or hormonal therapy are to determine the effects of 4 fam...

What is the current status of trial NCT01582971?

This trial is currently completed. It is a NA study. The enrollment target is 256 participants. The study started on 2012-04-17. Estimated completion is 2016-05.

What interventions are being tested in trial NCT01582971?

The interventions under investigation include: Reflexology (OTHER).

Who is sponsoring clinical trial NCT01582971?

This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01582971's enrollment target sits among peer trials

256 404th of 2000 higher than 1,594 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02464696 · 256 participants · NA

    Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

  • NCT03793062 · 256 participants

    Genetic and Epigenetic Basis of Chronic Wounds

  • NCT04322318 · 256 participants · Phase 2

    A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

  • NCT04468360 · 256 participants · Phase 2

    Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01582971, the US trial registry maintained by the National Library of Medicine. NCT01582971 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.